These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

469 related articles for article (PubMed ID: 23969907)

  • 1. Treatment of intrabony defects with anorganic bone matrix/p-15 or guided tissue regeneration in patients with aggressive periodontitis.
    Queiroz AC; Nóbrega PB; Oliveira FS; Novaes AB; Taba M; Palioto DB; Grisi MF; Souza SL
    Braz Dent J; 2013; 24(3):204-12. PubMed ID: 23969907
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical effectiveness of autologous platelet-rich plasma and Peptide-enhanced bone graft in the treatment of intrabony defects.
    Pradeep AR; Shetty SK; Garg G; Pai S
    J Periodontol; 2009 Jan; 80(1):62-71. PubMed ID: 19228091
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment of intrabony defects using guided tissue regeneration or enamel matrix derivative: a 3-year prospective randomized clinical study.
    Crea A; Dassatti L; Hoffmann O; Zafiropoulos GG; Deli G
    J Periodontol; 2008 Dec; 79(12):2281-9. PubMed ID: 19053918
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of platelet-rich plasma, bovine porous bone mineral, and guided tissue regeneration versus platelet-rich plasma and bovine porous bone mineral in the treatment of intrabony defects: a reentry study.
    Lekovic V; Camargo PM; Weinlaender M; Vasilic N; Kenney EB
    J Periodontol; 2002 Feb; 73(2):198-205. PubMed ID: 11895286
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Five-year clinical results for treatment of intrabony defects with EMD, guided tissue regeneration and open-flap debridement: a case series.
    Mitani A; Takasu H; Horibe T; Furuta H; Nagasaka T; Aino M; Fukuda M; Fujimura T; Mogi M; Noguchi T
    J Periodontal Res; 2015 Feb; 50(1):123-30. PubMed ID: 24815103
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A surgical reentry study on the influence of platelet-rich plasma in enhancing the regenerative effects of bovine porous bone mineral and guided tissue regeneration in the treatment of intrabony defects in humans.
    Camargo PM; Lekovic V; Weinlaender M; Divnic-Resnik T; Pavlovic M; Kenney EB
    J Periodontol; 2009 Jun; 80(6):915-23. PubMed ID: 19485821
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Use of bovine-derived anorganic bone associated with guided tissue regeneration in intrabony defects. Six-month evaluation at re-entry.
    Batista EL; Novaes AB; Simonpietri JJ; Batista FC
    J Periodontol; 1999 Sep; 70(9):1000-7. PubMed ID: 10505802
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A novel marginal periosteal pedicle graft as an autogenous guided tissue membrane for the treatment of intrabony periodontal defects.
    Gamal AY; Mailhot JM
    J Int Acad Periodontol; 2008 Oct; 10(4):106-17. PubMed ID: 19055224
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Combined periodontal regenerative technique in human intrabony defects by collagen membranes and anorganic bovine bone. A controlled clinical study.
    Paolantonio M
    J Periodontol; 2002 Feb; 73(2):158-66. PubMed ID: 11895280
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Platelet-rich plasma and bovine porous bone mineral combined with guided tissue regeneration in the treatment of intrabony defects in humans.
    Camargo PM; Lekovic V; Weinlaender M; Vasilic N; Madzarevic M; Kenney EB
    J Periodontal Res; 2002 Aug; 37(4):300-6. PubMed ID: 12200975
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Radiographic outcomes following treatment of intrabony defect with guided tissue regeneration in aggressive periodontitis.
    Rakmanee T; Griffiths GS; Auplish G; Darbar U; Petrie A; Olsen I; Donos N
    Clin Oral Investig; 2016 Jul; 20(6):1227-35. PubMed ID: 26452978
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Five-year results of a prospective, randomized, controlled study evaluating treatment of intra-bony defects with a natural bone mineral and GTR.
    Sculean A; Schwarz F; Chiantella GC; Donos N; Arweiler NB; Brecx M; Becker J
    J Clin Periodontol; 2007 Jan; 34(1):72-7. PubMed ID: 17243997
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Five-year results of guided tissue regeneration in combination with deproteinized bovine bone (Bio-Oss) in the treatment of intrabony periodontal defects: a case series report.
    Stavropoulos A; Karring T
    Clin Oral Investig; 2005 Dec; 9(4):271-7. PubMed ID: 16010581
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Autogenous periosteal barrier membranes and bone grafts in the treatment of periodontal intrabony defects of single-rooted teeth: a 12-month reentry randomized controlled clinical trial.
    Paolantonio M; Femminella B; Coppolino E; Sammartino G; D'Arcangelo C; Perfetti G; Perinetti G
    J Periodontol; 2010 Nov; 81(11):1587-95. PubMed ID: 20583915
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Use of anorganic bovine-derived hydroxyapatite matrix/cell-binding peptide (P-15) in the treatment isolated Class I gingival recession of defects: a pilot study.
    Nazareth CA; Cury PR
    J Periodontol; 2011 May; 82(5):700-7. PubMed ID: 21080787
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gingival crevicular fluid vascular endothelial cell growth factor and platelet-derived growth factor-BB release profile following the use of perforated barrier membranes during treatment of intrabony defects: a randomized clinical trial.
    Gamal AY; Abdel-Ghaffar KA; Iacono VJ
    J Periodontal Res; 2016 Jun; 51(3):407-16. PubMed ID: 26549803
    [TBL] [Abstract][Full Text] [Related]  

  • 17. GTR treatment of intrabony defects in patients with early-onset and chronic adult periodontitis.
    Zucchelli G; Brini C; De Sanctis M
    Int J Periodontics Restorative Dent; 2002 Aug; 22(4):323-33. PubMed ID: 12212679
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treatment of intrabony defects with resorbable materials, non-resorbable materials and flap debridement.
    Zybutz MD; Laurell L; Rapoport DA; Persson GR
    J Clin Periodontol; 2000 Mar; 27(3):169-78. PubMed ID: 10743863
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Combination use of bovine porous bone mineral, enamel matrix proteins, and a bioabsorbable membrane in intrabony periodontal defects in humans.
    Lekovic V; Camargo PM; Weinlaender M; Kenney EB; Vasilic N
    J Periodontol; 2001 May; 72(5):583-9. PubMed ID: 11394392
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of clinical, radiographic, and histometric measurements following treatment with guided tissue regeneration or enamel matrix proteins in human periodontal defects.
    Windisch P; Sculean A; Klein F; Tóth V; Gera I; Reich E; Eickholz P
    J Periodontol; 2002 Apr; 73(4):409-17. PubMed ID: 11990442
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.